IGF-LR3

IGF-1 LR3 is a modified analog of insulin-like growth factor 1 studied for its interaction with IGF receptors and cellular growth signaling pathways [1,2].

This peptide is for research purposes only. Not for human consumption.

Category:

Description

Receptor Binding and Signaling

The LR3 modification alters receptor affinity and binding kinetics, allowing detailed signaling analysis [1].

Cell Growth Pathway Research

Studies explore IGF-LR3 in relation to proliferation, differentiation, and metabolic signaling models [2].

Comparative Growth Factor Studies

IGF-LR3 is often compared with native IGF-1 to examine structural and signaling differences [1].

Key Specs

  • Peptide class: IGF-1 analog
  • Research context: growth factor signaling
  • References: PubChem, PubMed [1,2]

Referenced Citations

  1. PubChem, IGF-1 LR3: https://pubchem.ncbi.nlm.nih.gov/compound/IGF-1-LR3
  2. PubMed, IGF-1 receptor signaling: https://pubmed.ncbi.nlm.nih.gov/7521358/

Reviews

There are no reviews yet.

Be the first to review “IGF-LR3”

Receptor Binding and Signaling

The LR3 modification alters receptor affinity and binding kinetics, allowing detailed signaling analysis [1].

Cell Growth Pathway Research

Studies explore IGF-LR3 in relation to proliferation, differentiation, and metabolic signaling models [2].

Comparative Growth Factor Studies

IGF-LR3 is often compared with native IGF-1 to examine structural and signaling differences [1].

Key Specs

  • Peptide class: IGF-1 analog
  • Research context: growth factor signaling
  • References: PubChem, PubMed [1,2]

Referenced Citations

  1. PubChem, IGF-1 LR3: https://pubchem.ncbi.nlm.nih.gov/compound/IGF-1-LR3
  2. PubMed, IGF-1 receptor signaling: https://pubmed.ncbi.nlm.nih.gov/7521358/
0
    Shopping Cart
    Your cart is emptyReturn to Shop